Literature DB >> 7538670

Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein.

A M Schneider1, I R Griffiths, C Readhead, K A Nave.   

Abstract

Mutations in genes encoding membrane proteins have been associated with cell death of unknown cause from invertebrate development to human degenerative diseases. A point mutation in the gene for myelin proteolipid protein (PLP) underlies oligodendrocyte death and dysmyelination in jimpy mice, an accurate model for Pelizaeus-Merzbacher disease. To distinguish the loss of PLP function from other effects of the misfolded protein, we took advantage of the X chromosomal linkage of the gene and have complemented jimpy with a wild-type PLP transgene. In this artificial heterozygous situation, the jimpy mutation emerged as genetically dominant. At the cellular level oligodendrocytes showed little increase in survival although endogenous PLP gene and autosomal transgene were truly coexpressed. In surviving oligodendrocytes, wild-type PLP was functional and immunodetectable in myelin. Moreover, compacted myelin sheaths regained their normal periodicity. This strongly suggests that, despite the presence of functional wild-type PLP, misfolded jimpy PLP is by itself the primary cause of abnormal oligodendrocyte death.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538670      PMCID: PMC41961          DOI: 10.1073/pnas.92.10.4447

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  An AG----GG transition at a splice site in the myelin proteolipid protein gene in jimpy mice results in the removal of an exon.

Authors:  W B Macklin; M V Gardinier; K D King; K Kampf
Journal:  FEBS Lett       Date:  1987-11-02       Impact factor: 4.124

2.  A single nucleotide difference in the gene for myelin proteolipid protein defines the jimpy mutation in mouse.

Authors:  K A Nave; F E Bloom; R J Milner
Journal:  J Neurochem       Date:  1987-12       Impact factor: 5.372

3.  Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin.

Authors:  K A Nave; C Lai; F E Bloom; R J Milner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 4.  Unwrapping the genes of myelin.

Authors:  G Lemke
Journal:  Neuron       Date:  1988-09       Impact factor: 17.173

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

6.  Death of individual oligodendrocytes in jimpy brain precedes expression of proteolipid protein.

Authors:  M K Vermeesch; P E Knapp; R P Skoff; D M Studzinski; J A Benjamins
Journal:  Dev Neurosci       Date:  1990       Impact factor: 2.984

7.  Oligodendroglial cell death in jimpy mice: an explanation for the myelin deficit.

Authors:  P E Knapp; R P Skoff; D W Redstone
Journal:  J Neurosci       Date:  1986-10       Impact factor: 6.167

8.  Differences in levels of neuroglial cell death in jimpy male mice and carrier females.

Authors:  P E Knapp; S Dutta; R P Skoff
Journal:  Dev Neurosci       Date:  1990       Impact factor: 2.984

9.  Jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing.

Authors:  K A Nave; C Lai; F E Bloom; R J Milner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Myelination in the jimpy mouse in the absence of proteolipid protein.

Authors:  I D Duncan; J P Hammang; S Goda; R H Quarles
Journal:  Glia       Date:  1989       Impact factor: 7.452

View more
  14 in total

Review 1.  The unfolded protein response in protein aggregating diseases.

Authors:  Alexander Gow; Ramaswamy Sharma
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

Review 2.  Myelin biogenesis: vesicle transport in oligodendrocytes.

Authors:  J N Larocca; A G Rodriguez-Gabin
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

3.  Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model.

Authors:  Thomas Prukop; Dirk B Epplen; Tobias Nientiedt; Sven P Wichert; Robert Fledrich; Ruth M Stassart; Moritz J Rossner; Julia M Edgar; Hauke B Werner; Klaus-Armin Nave; Michael W Sereda
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

4.  Genetic background influences UPR but not PLP processing in the rumpshaker model of PMD/SPG2.

Authors:  M McLaughlin; S A Karim; P Montague; J A Barrie; D Kirkham; I R Griffiths; J M Edgar
Journal:  Neurochem Res       Date:  2006-08-31       Impact factor: 3.996

5.  Mutant Plp/DM20 cannot be processed to secrete PLP-related oligodendrocyte differentiation/survival factor.

Authors:  M Yamada; M Jung; K Tetsushi; A Ivanova; K A Nave; K Ikenaka
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

6.  Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice.

Authors:  M Jung; I Sommer; M Schachner; K A Nave
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

Review 7.  PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.

Authors:  Ken Inoue
Journal:  Neurogenetics       Date:  2004-12-31       Impact factor: 2.660

8.  Proteolipid protein gene product can be secreted and exhibit biological activity during early development.

Authors:  M Yamada; A Ivanova; Y Yamaguchi; M B Lees; K Ikenaka
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

9.  The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease.

Authors:  Cherie M Southwood; James Garbern; Wei Jiang; Alexander Gow
Journal:  Neuron       Date:  2002-11-14       Impact factor: 17.173

10.  Identification of GPM6A and GPM6B as potential new human lymphoid leukemia-associated oncogenes.

Authors:  Cyndia Charfi; Elsy Edouard; Eric Rassart
Journal:  Cell Oncol (Dordr)       Date:  2014-06-12       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.